SEPPRO
DEAD

Serial Number

78359775

Owner

SIGMA-ALDRICH CO., LLC

Attorney

William C. Wright

First Use Date

Jan 28, 2004

Filing Date

Jan 29, 2004

Add to watchlist:

No watchlists yet
View on USPTO

SEPPRO Trademark

Serial Number: 78359775 • Registration: 3007344

SEPPRO is a trademark filed by SIGMA-ALDRICH CO., LLC on January 29, 2004. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

SIGMA-ALDRICH CO., LLC

3050 Spruce Street
Saint Louis, MO 63103

Entity Type: 16

GenWay Biotech, Inc. (9 trademarks)

San Diego, CA 92111

Entity Type: 03

SIGMA-ALDRICH BIOTECHNOLOGY L.P. (112 trademarks)

3050 SPRUCE STREET
ST. LOUIS, MO 63103

Entity Type: 13

MERCK KGAA (1,594 trademarks)

DARMSTADT 64293 , DE

Entity Type: 31

Trademark Details

Filing Date

January 29, 2004

Registration Date

October 18, 2005

First Use Anywhere

January 28, 2004

First Use in Commerce

January 28, 2004

Published for Opposition

July 26, 2005

Cancellation Date

May 1, 2026

Goods & Services

Product development, medical and laboratory research in the field of proteomics, namely the science, system, components, organization, function, and biomedical applications of separation of abundant proteins, especially, in the area of proteomics sample processing that permits highly selective separation of abundant proteins, such as albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; development of chemical markers that indicate the presence of disease states; determining biological targets for drugs, namely determining biological processes that are susceptible to being affected by drugs in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets; developing methodologies relating to the previous services such as developing bioanalytical methods to increase sensitivity, specificity and throughput of identifying and characterizing biological substances such as protein, peptides, hormones, lipids, used as biomarkers for a diagnosis or as drug targets

Reagents for fractionating target proteins from complex biological fluids, such as plasma, serum, CSF, urine or other tissue or cellular sources, and the subsequent chemical analysis of compounds physiologically associated with abundant proteins including proteins, peptides, fatty acids, hormones, glycosylation states, phosphorylation states, etc; Reagents for diagnosis of diseases associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; Immunoaffinity reagents for developing chemical markers that indicate the presence of disease states associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3; Reagents for determining biological targets for drugs, namely determining biological processes that are susceptible to being affected by drugs in order that the drugs may alleviate disease states and conditions related to albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3 and associated compounds in humans and animals; Reagents for determining protein and peptide sequences for the purposes of identifying protein or peptide drug targets associated with albumin, IgG, Fibrinogen, Transferrin, IgA, IgM, a2-Macroglobulin, a1-Acid Glycoprotein, a1-Antitrypsin, Haptoglobin, High Density Lipoproteins, Complement C3, all for research use

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
May 1, 2026 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Oct 18, 2024 REM2
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 20, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 20, 2021 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 20, 2021 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 20, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 20, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 20, 2021 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 28, 2020 ASGN
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Sep 22, 2015 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Sep 22, 2015 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Sep 22, 2015 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 22, 2015 APRE
TEAS SECTION 8 & 9 RECEIVED
Aug 24, 2015 E89R
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 24, 2015 TCCA
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Apr 21, 2012 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Apr 21, 2012 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 21, 2012 APRE
TEAS SECTION 8 & 15 RECEIVED
Apr 9, 2012 E815
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 4, 2011 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 4, 2011 REAP
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 14, 2011 ASCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Mar 11, 2009 ASGN
REGISTERED-PRINCIPAL REGISTER
Oct 18, 2005 R.PR
PUBLISHED FOR OPPOSITION
Jul 26, 2005 PUBO
NOTICE OF PUBLICATION
Jul 6, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
May 26, 2005 PREV
ASSIGNED TO LIE
May 23, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 13, 2005 CNSA
EXAMINERS AMENDMENT E-MAILED
May 13, 2005 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 13, 2005 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 11, 2005 ZZZX
WITHDRAWN BEFORE PUBLICATION
Apr 22, 2005 CWBP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 27, 2005 PREV
ASSIGNED TO LIE
Jan 25, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 11, 2005 CNSA
EXAMINERS AMENDMENT E-MAILED
Jan 10, 2005 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 10, 2005 CNEA
AMENDMENT FROM APPLICANT ENTERED
Dec 8, 2004 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2004 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 1, 2004 TROA
NON-FINAL ACTION E-MAILED
Aug 26, 2004 GNRT
ASSIGNED TO EXAMINER
Aug 20, 2004 DOCK
NEW APPLICATION ENTERED
Feb 9, 2004 NWAP